![]() Editas Medicine Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics. | ![]() CellGenix CellGenix is a supplier of raw and ancillary materials for the market of cell and gene therapy and regenerative medicine. | |||
Founding Date | Founding Date 2008 | Founding Date 2013 | Founding Date 2012 | Founding Date 1994 |
Type | Type Subsidiary | Type Public | Type Private | Type Private |
Tags | ||||
Locations | Locations Waltham, US HQ Beijing, CN Nantong, CN Shanghai, CN Heidelberg, DE San Diego, US San Francisco, US | Locations Cambridge, US HQ Boulder, US Cambridge, US | Locations Stevenage, GB HQ Tres Cantos, ES | Locations Freiburg im Breisgau, DE HQ Newington, US |
Employees | Employees 1833% increase | Employees 20816% increase | Employees 13 | Employees 711% increase |
Funding | ||||
Total funding raised | Total funding raised $ 284.3m | Total funding raised $ 210m | Total funding raised N/A | Total funding raised N/A |

Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
View companyAglaris is a company automating and controlling the cell culture processes.
View company
CellGenix is a supplier of raw and ancillary materials for the market of cell and gene therapy and regenerative medicine.
View company